Cargando…
Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes
Although radiotherapy (RT) is widely used to control tumor growth across many cancer types, there is a relatively high incidence of RT failure exhibited by tumor recurrence, therefore a clear need exists to achieve improved effectiveness of RT. The RT-elicited immune response largely impacts the eff...
Autores principales: | Connolly, Kelli A., Belt, Brian A., Figueroa, Nathania M., Murthy, Aditi, Patel, Ankit, Kim, Minsoo, Lord, Edith M., Linehan, David C., Gerber, Scott A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349932/ https://www.ncbi.nlm.nih.gov/pubmed/27852031 http://dx.doi.org/10.18632/oncotarget.13287 |
Ejemplares similares
-
Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
por: Lim, Herman D., et al.
Publicado: (2021) -
Role of the Chemokine Receptors CCR1, CCR2 and CCR4 in the Pathogenesis of Experimental Dengue Infection in Mice
por: Guabiraba, Rodrigo, et al.
Publicado: (2010) -
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
por: Korbecki, Jan, et al.
Publicado: (2020) -
Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3
por: Shao, Zhehua, et al.
Publicado: (2022) -
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
por: Korbecki, Jan, et al.
Publicado: (2020)